1. Taieb A, Picardo. Vitiligo. N Engl J Med 2009, 8 (360):
160.
2. Yaghoobi R, Omidian M, Bagherani N. Vitiligo: a review of the
published work. J Dermatol. 2011; 38 (5): 419-31.
3. Majumder PP, Nordlund JJ, Nath SK. Pattern of familial
aggregation of vitiligo. Arch Dermatol 1993; 129: 994-8.
4.
http://www.afvitiligo.com/index.php?option=com_content&view=article
(consulté le 15/05/2012).
5. Howitz J, Brodthagen H, Schwartz M, Thomsen K. Prevalence of
vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch
Dermatol. 1977; 113(1): 47-52.
6. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a
comprehensive overview . J Am Acad Dermatol. 2011; 65(3): 473-91.
7. Handa S, Kaur I. Vitiligo: clinical findings in 1436
patients. J Dermatol. 1999; 26(10): 653-7.
8. Wang Xiaoyan , Yu Ting-Lin, Zhou Cheng et coll.
Prévalence du vitiligo en Chine. Chinese Journal of Dermatology 2010,
43(7): 463-466.
9. Shah H, Mehta A, Astik B. Clinical and sociodemographic study
of vitiligo. Indian J Dermatol Venerol Leprol. 2008 ; 74(6): 701.
10. Giam YC. Skin diseases in children in Singapore. Ann Acad
Med Singapore. 1988; 17(4): 569-72.
11. Ayanlowo O, Olumide YM, Akinkugbe A, et coll.
Characteristics of vitiligo in Lagos, Nigeria. Afr J Med. 2009; 28(2):
118-21.
12. Niang S.O.,Maado Ndaye, Fatima LY et coll. le vitiligo au
Sénégal. ISRN Dermatol.2012 ; 2012: 932163.epub 2012.
13. Bieleli E, Moswa Jl, Ditu Mpandamadi S et coll.
Prévalence du diabète sucré au sein de la population de
Kinshasa. Congo Médical 2000 ; 2(15): 1055-61.
14. Pegum JS. Vitiligo. Br J Dermatol 1996; 134:373.
15. Bielili E, Isis. Le Goitre Hyperthyroidien. Med Afr Noire:
1993, 40(8/9).
16. Carter RL. Dictionnaire des termes dermatologique. 4 e
éd. Williams et Wilkins: Baltimore, 1992.
17.
http://dermographie.info/vitiligo/vitiligo_dr_yvon_gauthier.php
(consulté le 27/10/2012).
18.
www.orpha.net/data/patho/pub/fr/vitiligo-Frfrpub672vo1.pdf.
(consulté le 10/09/2012).
19. Nordlund JJ. The epidemiology and genetics of vitiligo. Clin
Dermatol 1997; 15: 875-8.
20. Srivastava G. Vitiligo, Clinique d'Asie. Dermatol 1994;
1:1-5.
21. Nordlund JJ, AB Lerner. Vitiligo-il est important ?. Arch
Dermatol 1982; 118: 5-8.
22. Monia Kharfi, Aida Khaled, Mohamed Ridha Kamoun. Vitiligo de
L'enfant : Mise au point. Société Française de
Dermatologie Pédiatrique, 2008.
23. Yvon Gauthier. Le vitiligo. Gazette medicale 1994, 101:
8-12.
24. Maresca V, Rocella M, Rocella F et coll. Increased sensi-
tivity to peroxidative agents as a possible pathogenic factor of melanoc yte
damage in vitiligo. J Invest Dermatol 1997; 109: 310-3.
25. Mohr J. Vitiligo in a pair of monovular twins. Acta Genet
Stat Med 1951; 2: 252-5.
26. Fain PR, Gowan K, LaBerge GS, et coll. A genomewide screen
for generalized vitiligo. Am J Hum Genet 2003 ; 72: 1560-4.
27. Arcos-Burgos M, Parodi E, Salgar M, et coll. Vitiligo:
complex segregation and linkage disequilibrium analyses with respect to
micro-satellite loci spanning the HLA. Hum Genet2002; 110: 334-42.
28.
http://www.dermatobordeaux.fr/content/view/46
(consulté le 20/08/2012).
29. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an
auto-immune pathogenesis of vitiligo. Pigment Cell Res 2003; 16: 90-100.
30. Bloch MH, Sowers JR. Vitiligo and polyglandular autoimmune
endocrinopathy. Cutis1985; 36: 417-9.
31. Hann Sk, Nordlund JJ. G. Neural pathogenesis in vitiligo.
Oxford: Black- well Science, 2000, 142p.
32. Morrone A, Picardo M, Luca C, et coll. Catecholamines and
vitiligo. Pigment Cell Res 1992; 5: 65-9.
33. Grimes PE, Sevall JS, Vojdani A. CMV DNA identified in skin
biopsy specimens of patients with vitiligo. J Am Acad Dermatol1996; 35:21-6.
34. Pegum JS. Vitiligo. Br J Dermatol 1996; 134: 373.
35. Behl PN. Examen des mesures thérapeutiques dans le
traitement du vitiligo. Indian J Dermtol Venereol 1957; 23: 17-24.
36. Fisher AA. Le diagnostic différentiel du vitiligo
idiopathique de Leucoderme Contact. Cutis 1994; 53: 232-4.
37. Handa S, Dogra S. Epidémiologie du vitiligo
enfantile: Une étude de 625 patients du nord de linde. Pediatr Dermatol
2003; 20: 207-10.
38. Drake L, Dinehart SM, Farmer ER. et coll . Lignes
directrices des soins aux patients vitiligo. J Am Acad Dermatol 1996; 35:
620-6.
39. Mathias CG, Maibach HI, Conant MA. Perioral leukoderma
stimulating vitiligo from use of toothpaste containing cinnamic aldehyde. Arch
Dermatol 1980; 116: 1172-3.
40. Behl PN, Aggarwal A, Srivastava G. Vitiligo: dans pratique
de la dermatologie. 9e éd. Editeurs CBS: New Delhi, 2003, 238p.
41. Hann SK, Kim YS, Yoo JH, Chun YS. Clinical and histological
characteristic of trichrome vitiligo.J Am Acad Dermatol 2000; 42: 589-96.
42. Dupre A, Christol B. Cockade - like vitiligo and linear
vitiligo a variant of Fitzpatrick's trichrome vitiligo. Arch Dermatol Res 1978;
262: 197-203.
43. Fargnoli MC, Bolognia JL. Pentachrome vitiligo. J Am Acad
Dermatol 1995;33:853-6.
44. Anatoli F , David G. Vitiligo, Conf Scient 2005; 4: 2p.
45. Halder RM, Grimes PE, Cowan CA, Enterline JA, Chakrabarti
SG, Kenney juge Jr. Enfance et vitiligo. J Am Acad Dermatol 1987; 16:
948-54.
46. Ortonne JP, Bahadoran P, Fitzpatrick TB. Hypomelanoses et
hypermelanose. Derm méd gén. Mc Graw-Hill: New York; 1999,
836p.
47. Midelfart K, Moseng D, Kavli G, et coll. Un cas d'urticaire
chronique et le vitiligo, associée à une thyroïdite,
traité par PUVA. Dermatologica 1983; 167: 39-41.
48. Kang IK, Hann SK. Vitiligo coexistent with nevus
dedepigmentosus. J Dermatol Tokyo 1996; 23: 187-90.
49. Downs AM, Lear JT, Dunnill MG. Lucite polymorphe
limitée aux zones de vitiligo. Clin Exp Dermatol 1999; 24: 379-81.
50. Okada T, Sakamoto T, Ishibashi T et coll. Vitiligo dans la
maladie de Vogt- Koyanagi-Harada. Graefes Arch Clin Exp Ophthalmol 1996; 234:
359-63.
51. Michaelsson G. Vitiligo with raised borders- report of two
cases. Acta Derm Venereol 1968; 48: 158-61.
52. Sehgal VN, Srivastava G. Vitiligo: Auto-immunity and immune
responses. Int J Dermatol 2006; 45: 583-90.
53. AJ Sober, H Nakagawa, Albert DM et coll. Malignant melanoma
and vitiligo-like leukoderma. J Am Acad Dermatol 1983; 9 (5): 696-708).
54.
www.orpha.net/data/patho/Pub/fr/Vitiligo-FRfrPub672v01
(consulté le 14/09/2011).
55. Hamzavi I, McLean D, Shapiro et coll. Parametric modeling of
narrowband UV-B phototherapy for vitiligo using a novel quantitative tool. Arch
Dermatol 2004; 140: 677-83.
56. Sehgal VN, Rege VL, Mascarenhas F, Kharangate VN. Tableau
clinique de vitiligo chez les Indiens. J Dermatol Tokyo 1976; 3: 49-53.
57. Lerner AB. Vitiligo. J Invest Dermatol 1959; 32: 285-310.
58.
http://www.medicinenet.com/vitiligo/article.htm
(consulté le 05/07/2012).
59. Urbanek RW. Tar vitiligo therapy. J am Acad Dermatol 1983 ;
8: 755.
60. Juhlin L, Olsson MJ. Improvement of Vitiligo after oral
treatment with vitamin B12 and folic acid and the importance of sun exposure.
Acta Derm venerol 1997; 77: 460-2.
61. Parsad D, Pandi R, Juneja A. Effectiveness of oral Ginkgo
iloba in treating limited, slowly spreading Vitiligo. Clin Exp Dermatol 2003;
28: 285-7.
62. Schallreuter KU, Wood JM, Lemke KR, Levening C. Treatment of
vitiligo with a topical application of pseudocatalase and calcium in
combination with short-term UVB exposure. Dermatology 1995; 190: 223-9.
63. Howitz J, Brodthagen H, Schwartz M et coll. Prevalence of
vitiligo. Denmark. Arch Dermatol. 1977; 113(1): 47-52.
64. Shajil EM , Deepali Agrawal, Krishna Vagadia et coll.
Vitiligo: profils cliniques à Vadodara, Gujarat . J Indien Dermatol
2006; 51: 100-4.
65. Whitton ME, M Pinart, Batchelor J, et coll. Interventions
pour le vitiligo. The Cochrane Library, Issue 1, 2010. Chichester, UK: John
Wiley & Sons.
66. Chaoui, Souad. Aspects épidémiologiques du
vitiligo au service de dermatologie du Chu Ibn Rochd. These.Université
Hassan II, Faculté de Médecine et de Pharmacie, Casablanca.
2005.
67. Berti S, Bellandi S, Bertelli A et coll. Vitiligo in an
italian outpatient center. Am J Clin Dermatol. 2011 Feb 1; 12(1): 43-9.
68. Paravar T, Lee DJ. Vitiligo in an urban academic setting.
Int J Dermatol. 2010;49(1): 39-43.
69. Ayanlowo O, Olumide YM, Akinkugbe A et coll. Characteristics
of vitiligo in Lagos, Nigeria. est Afr J Med. 2009; 28(2): 118-21.
70. Zeglaoui F, Souissi A, Ben Ayed A et coll. Epidemiological
and clinical profile of vitiligo in Tunisia, Tunis Med. 2007; 85(12):
1016-9.
71. Shah H, Mehta A, Astik B. Clinical and sociodemographic
study of vitiligo. Indian J Dermatol Venereol Leprol. 2008; 74(6): 701.
72. Gönül M, Cakmak SK, 2 ~IXJ D, Gül U,
Kiliç S. Profile of vitiligo patients attending a training and research
hospital in Central Anatolia. J Dermatol. 2012; 39(2): 156-9.
73. Ahmed K, Muhammad Z. Prevalence of cutaneous manifestations
of diabetes mellitus. Qayum I. J Ayub Med Coll Abbottabad. 2009 ; 21(2):
76-9.
74. Mantoux F, Ortonne JP. Physiologie du système
pigmentaire. Encycl Med Chir, Dermatologie, 98-015-A-10, 2003, 10p.
75. Ortonne JP, Grosshans E. Les troubles de la pigmentation
cutanée. Dermatologie et Maladies Sexuellement Transmissibles.
Paris, France: Masson; 1999, 407#177;426p.
76. Anstey A, Marks R. Colocalization of lichen planus and
vitiligo. Br J Dermatol 1993; 128 : 103-4.
77. Martis J, R Bhat, B Nandakishore, JN Shetty. Une
étude clinique de vitiligo. J Dermatol indiennes
Vénéréologie Leprol 2002; 68:92-3
78. Nunes DH, Esser LM. Vitiligo epidemiological profile and the
association with thyroid disease. An Bras Dermatol. 2011; 86(2): 241-8.
79. Huggins RH, Janusz CA, Schwartz RA. Vitiligo: A sign of
systemic disease. Indian J Dermatol Venereol Leprol 2006; 72: 68-71.
80. Mazereeuw - Hautier. Pathogénie du vitiligo.
Kératin 2004 ; 8 : 9-13.
81. Habib A, Raza N. Clinical pattern of vitiligo. J Coll
Physicians Surg Pak. 2012; 22(1): 61-2.
82. Belliappa PR, Priya KS, Umashankar N et coll.
Characteristics of childhood vitiligo in bangalore with special reference to
associated ocular abnormali- ties. e-journal of the indian society of
teledermatology, 2011; Vol 4, No.3
83. Herane MI. Vitiligo and leukoderma in children. Clin
Dermatol 2003; 21: 283-95.
84. Jaigirdar MQ, Alam SM, Maidul AZ . Clinical presentation of
vitiligo. Mymensingh Med J 2002; 11: 79-81.
